Items where Author is "Fontrier, Anna-Maria"

Number of items: 13.
  • Market access for medicines treating rare diseases:association between specialised processes for orphan medicines and funding recommendations. (2022) Fontrier, Anna-Maria picture_as_pdf
  • Similarities and differences in Health Technology Assessment systems and implications for coverage decisions:evidence from 32 countries. (2022) Fontrier, Anna-Maria and Visintin, Erica and Kanavos, Panos picture_as_pdf
  • Access to medicines in Europe delays and challenges for patient access:delays and challenges for patient access. Kamphuis, Bregtje and Fontrier, Anna-Maria and Gill, Jennifer and Efthymiadou, Olina and Salyga, Hana and Kanavos, Panos
  • Access to personalised oncology in Europe. Gill, Jennifer and Fontrier, Anna-Maria and Miracolo, Aurelio and Kanavos, Panos
  • Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia. Kamphuis, Bregtje and Fontrier, Anna-Maria and Haig, Madeleine and Politopoulou, Konstantina and Salyga, Hana and Gentilini, Arianna and Kanavos, Panos picture_as_pdf
  • Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the Canadian province of Ontario? Fontrier, Anna-Maria and Kanavos, Panos picture_as_pdf
  • How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe. Fontrier, Anna-Maria and Kamphuis, Bregtje W. and Kanavos, Panos picture_as_pdf
  • The Impact of External Reference Pricing within and across Countries. Kanavos, Panos and Fontrier, Anna-Maria and Gill, Jennifer and Efthymiadou, Olina and Boekstein, Nicola
  • The Implementation of External Reference Pricing within and across Country Borders. Kanavos, Panos and Fontrier, Anna-Maria and Gill, Jennifer and Kyriopoulos, Dionysis and Boekstein, Nicola
  • International impact of external reference pricing:should national policy makers care? Fontrier, Anna-Maria and Gill, Jennifer and Kanavos, Panos picture_as_pdf
  • Pricing of in-patent pharmaceuticals in the Middle East and North Africa:is external reference pricing implemented optimally? Kanavos, Panos and Kamphuis, Bregtje and Fontrier, Anna-Maria and Parkin, Georgia Colville and Saleh, Shadi and Akhras, Kasey S. picture_as_pdf
  • Sustainable healthcare financing for SDG3 in ASEAN-6. Gill, Jennifer and Chávez, Danitza and Main, Caitlin and Miracolo, Aurelio and Fontrier, Anna-Maria and Kanavos, Panos picture_as_pdf
  • Variations in external reference pricing implementation:does it matter for public policy? Gill, Jennifer and Fontrier, Anna-Maria and Kyriopoulos, Dionysis and Kanavos, Panos description